Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 and influenza: a comparative overview and treatment implications.

Boletin medico del Hospital Infantil de Mexico - 1 Jan 2020

Manzanares-Meza Laura D, Medina-Contreras Oscar

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Alphainfluenzavirus are RNA viruses that cause coronavirus disease-19 and influenza, respectively. Both viruses infect the respiratory tract, show similar symptoms, and use surface proteins to infect the host. Influenza requires hemagglutinin and neuraminidase to infect, whereas SARS-CoV-2 uses protein S. Both viruses depend on a viral RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Betacoronavirus
Share to Coronavirus Infections
Share to COVID-19 Drug Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Influenza A virus

Share to Pandemics

Share to Pneumonia, Viral

Share to Viral Vaccines

Source

Identifiers

PMID: 33064680
DOI: 10.24875/BMHIM.20000183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 and influenza: a comparative overview and treatment implications.PMID 33064680Read ↗

The Human Coronaviruses (HCoVs) and the Molecular Mechanisms of SARS-CoV-2 InfectionSemantic proximity Read ↗

Effect of Vaccination Against Influenza Viruses on Infection, Hospitalization, and Death from Respiratory COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read ↗

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Semantic proximity Read ↗

Antivirals and Biologics for Broader Coverage Against Human CoronavirusesSemantic proximity Read ↗

Novel Drugs Targeting the SARS-CoV-2/COVID-19 MachinerySemantic proximity Read ↗

Severe Acute Respiratory Syndrome Coronavirus-2 Emergence and Its Treatment with Alternative Medicines: A ReviewSemantic proximity Read ↗

New treatments for influenzaSemantic proximity Read ↗

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A virusesSemantic proximity Read ↗

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read ↗

SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virusSemantic proximity Read ↗

Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.